Factors related to the experience of menopausal symptoms in women prescribed tamoxifen

References

• Archer DF, Sturdee DW, Baber R, et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 2011;14:515–28.
   PubMed Web of Science ®Google Scholar
• Harris PF, Remington PL, Trentham-Dietz A, et al. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage 2002;23:501–9.
   PubMed Web of Science ®Google Scholar
• Carpenter JS, Johnson D, Wagner L, Andrykowski M. Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 2002;29:E16–25.
   PubMedGoogle Scholar
• Marino JL, Saunders CM, Emery LI, et al. Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history. Menopause 2014;21:267–74.
   PubMed Web of Science ®Google Scholar
• Morales L, Neven P, Timmerman D, et al. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs 2004;15:753–60.
   PubMed Web of Science ®Google Scholar
• Harrell JC, Dye WW, Harvell DM, et al. Estrogen insensitivity in a model of oestrogen receptor positive breast cancer lymph node metastasis. Cancer Res 2007;67:10582–91.
   PubMed Web of Science ®Google Scholar
• Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. The Lancet 2013;381:805–16.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Medicines Evidence Commentary: Breast Cancer: Preliminary results from the ATLAS study show extended adjuvant tamoxifen reduces breast cancer recurrence and mortality [Internet]. NICE; April 2013. Available from: https://arms.evidence.nhs.uk/resources/hub/1010786/attachment [last accessed 11 Aug 2016].
   Google Scholar
• Sayakhot P, Vincent A, Deeks A, Teede H. Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer. Menopause 2011;18:786–93.
   PubMed Web of Science ®Google Scholar
• Hunter MS, Grunfeld EA, Mittal S, et al. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psycho-Oncology 2004;13:769–78.
   PubMed Web of Science ®Google Scholar
• Gupta P, Sturdee DW, Palin SL, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006;9:49–58.
   PubMed Web of Science ®Google Scholar
• Garreau JR, Delamelena T, Walts D, et al. Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg 2006;192:496–8.
   PubMed Web of Science ®Google Scholar
• Boehm DU, Lebrecht A, Eckhardt T, et al. Quality of life and adjuvant tamoxifen treatment in breast cancer patients. Eur J Cancer Care (Engl) 2009;18:500–6.
   PubMed Web of Science ®Google Scholar
• Stein KD, Jacobsen PB, Hann DM, et al. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage 2000;19:436–45.
   PubMed Web of Science ®Google Scholar
• Neugut AI, Subar M, Wilde ET, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 2011;29:2534–42.
   PubMed Web of Science ®Google Scholar
• Kuba S, Ishida M, Shigechi T, et al. Persistence and discontinuation of adjuvant endocrine therapy in Japanese women with breast cancer. Breast 2013;22:S83.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Clinical Guidance NG23. Menopause diagnosis and management [Internet]. NICE; 12th November 2015. Available from: http://nice.org.uk/guidance/ng23 [last accessed 11 Aug 2016].
   Google Scholar
• L’Espérance S, Frenette S, Dionne A, Dionne J-Y. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations. Support Care Cancer 2013;21:1461–74.
   PubMed Web of Science ®Google Scholar
• Morgan A, Fenlon DR, National Cancer Research Institute Clinical Studies Group Breast Cancer Working Party on Symptom Management. Is it me or is it hot in here? a plea for more research into hot flushes. Clin Oncol (R Coll Radiol) 2013;25:681–3.
   PubMed Web of Science ®Google Scholar
• Fenlon DR, Khambhaita P, Hunter MS. Helping patients to help themselves after breast cancer treatment. Clin Oncol (R Coll Radiol) 2015;27:640–6.
   PubMed Web of Science ®Google Scholar
• Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;159:1189–99.
   PubMed Web of Science ®Google Scholar
• Hunter MS, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10 418 British women aged 54–65. BJOG 2012;119:40–50.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, et al. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol 2011;117:1095–104.
   PubMed Web of Science ®Google Scholar
• Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000;152:463–73.
   PubMed Web of Science ®Google Scholar
• Li C, Samsioe G, Borgfeldt C, et al. Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study). Am J Obstet Gynecol 2003;189:1646–53.
   PubMed Web of Science ®Google Scholar
• Lee M-S, Kim J-H, Park MS, et al. Factors influencing the severity of menopause symptoms in Korean post-menopausal women. J Korean Med Sci 2010;25:758–65.
   PubMed Web of Science ®Google Scholar
• Pimenta F, Maroco J, Ramos C, Leal I. Hot flushes and night sweats in midlife: why do some women have them and others do not? Psicol Reflex Crít 2015;28:753–63.
   Web of Science ®Google Scholar
• Hunter MS, Mann E. A cognitive model of menopausal hot flushes and night sweats. J Psychosom Res 2010;69:491–501.
   PubMed Web of Science ®Google Scholar
• Hunter MS. 3 Predictors of menopausal symptoms: psychosocial aspects. Baillières Clin Endocrinol Metab 1993;7:33–45.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, et al. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005;12:258–66.
   PubMed Web of Science ®Google Scholar
• Hunter MS, Liao K. A psychological analysis of menopausal hot flushes. Br J Clin Psychol 1995;34:589–99.
   PubMed Web of Science ®Google Scholar
• Rendall MJ, Simonds LM, Hunter MS. The Hot Flush Beliefs Scale: a tool for assessing thoughts and beliefs associated with the experience of menopausal hot flushes and night sweats. Maturitas 2008;60:158–69.
   PubMed Web of Science ®Google Scholar
• Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 1992;16:143–63.
   Web of Science ®Google Scholar
• Rief W, Nanke A, Emmerich J, et al. Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior. J Psychosom Res 2004;57:367–71.
   PubMed Web of Science ®Google Scholar
• Faller H, Schilling S, Lang H. Causal attribution and adaptation among lung cancer patients. J Psychosom Res 1995;39:619–27.
   PubMed Web of Science ®Google Scholar
• Roesch SC, Weiner B. A meta-analytic review of coping with illness: do causal attributions matter? J Psychosom Res 2001;50:205–19.
   PubMed Web of Science ®Google Scholar
• Heidrich SM, Egan JJ, Hengudomsub P, Randolph SM. Symptoms, symptom beliefs, and quality of life of older breast cancer survivors: a comparative study. Pittsburgh, PA: Oncology Nursing Society; 2006:315.
   Google Scholar
• Mann E, Smith MJ, Hellier J, et al. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol 2012;13:309–18.
   PubMed Web of Science ®Google Scholar
• Duijts SF, van Beurden M, Oldenburg HS, et al. Efficacy of cognitive behavioural therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomised, controlled, multicenter trial. J Clin Oncol 2012;30:4124–33.
   PubMed Web of Science ®Google Scholar
• Hunter MS, Chilcot J. Testing a cognitive model of menopausal hot flushes and night sweats. J Psychosom Res 2013;74:307–12.
   PubMed Web of Science ®Google Scholar
• Moss-Morris R, Weinman J, Petrie KJ, et al. The revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002;17:1–16.
   Web of Science ®Google Scholar
• Fallowfield LJ, Leaity SK, Howell A, et al. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 1999;55:189–99.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Matthews EE, Berger AM, Schmiege SJ, et al. Cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: a randomized, controlled trial. Oncol Nurs Forum 2014;41:241–53.
   PubMed Web of Science ®Google Scholar
• Stanton AL, Petrie KJ, Partridge AH. Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Res Treat 2014;145:525–34.
   PubMed Web of Science ®Google Scholar
• Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. J Person Assess 1988;52:30–41.
   Web of Science ®Google Scholar
• Oztunc G, Yesil P, Paydas S, Erdogan S. Social support and hopelessness in patients with breast cancer. Asian Pac J Cancer Prev 2013;14:571–8.
   PubMedGoogle Scholar
• Cohen M, Numa M. Posttraumatic growth in breast cancer survivors: a comparison of volunteers and non-volunteers. Psycho-Oncology 2011;20:69–76.
   PubMed Web of Science ®Google Scholar
• Cella D, Fallowfield LJ. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat 2008;107:167–80.
   PubMed Web of Science ®Google Scholar
• Kligman L, Younus J. Management of hot flashes in women with breast cancer. Curr Oncol 2010;17:81–6.
   PubMed Web of Science ®Google Scholar
• Love RR, Cameron L, Connell BL, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991;151:1842–7.
   PubMed Web of Science ®Google Scholar
• Rohatgi N, Blau R, Lower EE. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. J Womens Health Gend Based Med 2002;11:291–301.
   PubMedGoogle Scholar
• Jones SE, Cantrell J, Vukelja S, et al. Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a tamoxifen exemestane adjuvant multicenter trial substudy. J Clin Oncol 2007;25:4765–71.
   PubMed Web of Science ®Google Scholar
• Fisher B, Brown A, Wolmark N, et al. Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. Ann Intern Med 1987;106:649–54.
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Zahasky KM, Sloan JA, et al. Tamoxifen-induced hot flashes. Clin Breast Cancer 2000;1:52–6.
   PubMedGoogle Scholar
• Hunter MS, Coventry S, Hamed H, et al. Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment. Psychooncology 2009;18:560–3.
   PubMed Web of Science ®Google Scholar
• Davis SR, Panjari M, Robinson PJ, et al. Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis. Menopause 2014;21:1075–81.
   PubMed Web of Science ®Google Scholar
• Dorjgochoo T, Gu K, Kallianpur A, et al. Menopausal symptoms among breast cancer patients 6 months after cancer diagnosis: a report from the Shanghai Breast Cancer Survival Study (SBCSS). Menopause (New York, NY) 2009;16:1205.
   PubMed Web of Science ®Google Scholar
• Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718–29.
   PubMed Web of Science ®Google Scholar
• Griffiths A, MacLennan SJ, Hassard J. Menopause and work: an electronic survey of employees’ attitudes in the UK. Maturitas 2013;76:155–9.
   PubMed Web of Science ®Google Scholar
• Jack G, Riach K, Bariola E, et al. Menopause in the workplace: what employers should be doing. Maturitas 2016;85:88–95.
   PubMed Web of Science ®Google Scholar
• Mullins E. Annual Report of the Chief Medical Officer, 2014: The Health of the 51%: Women. [Internet]. Department for Health; December 2015. Available from: http://www.rcgp.org.uk/clinical-and-research/toolkits/~/media/A015853C3C22448583712961D42CA9E8.ashx [last accessed 11 Aug 2016].
   Google Scholar
• Fenlon D, Corner J, Haviland J. Menopausal hot flushes after breast cancer. Eur J Cancer Care 2009;18:140–8.
   PubMed Web of Science ®Google Scholar
• Whiteman MK, Staropoli CA, Benedict JC, et al. Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) 2003;12:459–72.
   PubMed Web of Science ®Google Scholar
• Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997;3:103–20.
   PubMedGoogle Scholar
• Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause (New York, NY) 2008;15:841.
   PubMed Web of Science ®Google Scholar
• Grisso JA, Freeman EW, Maurin E, et al. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 1999;14:98–103.
   PubMed Web of Science ®Google Scholar
• Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause 2015;22:1155–72. quiz 1173–4.
   PubMed Web of Science ®Google Scholar
• Shifren JL, Gass ML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause 2014;21:1038–62.
   PubMed Web of Science ®Google Scholar